Edition:
United Kingdom

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

1.75USD
18 Jan 2019
Change (% chg)

$-0.77 (-30.56%)
Prev Close
$2.52
Open
$2.77
Day's High
$5.04
Day's Low
$1.73
Volume
2,533,418
Avg. Vol
3,835
52-wk High
$61.60
52-wk Low
$1.73

Latest Key Developments (Source: Significant Developments)

Bio-Path Holdings Announces 1-For-20 Reverse Stock Split
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT.BIO PATH- AS RESULT OF REVERSE STOCK SPLIT, EVERY 20 SHARES OF COMMON STOCK ISSUED AND OUTSTANDING WERE CONSOLIDATED INTO 1 ISSUED AND OUTSTANDING SHARE.REVERSE STOCK SPLIT REDUCED CO’S ISSUED AND OUTSTANDING SHARES OF COMMON STOCK FROM ABOUT 22.2 MILLION TO ABOUT 1.1 MILLION.  Full Article

Bio-Path Holdings Announces Pricing Of Public Offering Of Common Stock
Tuesday, 15 Jan 2019 

Jan 14 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 8.6 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $0.13 PER SHARE.BIO-PATH EXPECTS TO RECEIVE AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $1.1 MILLION FROM OFFERING.  Full Article

Bio Path Holdings Inc Says Board Approved Ratio For Reverse Stock Split Of 1-For-20
Monday, 14 Jan 2019 

Jan 14 (Reuters) - Bio Path Holdings Inc ::BIO PATH HOLDINGS INC - ON JANUARY 11, 2019, BOARD OF DIRECTORS APPROVED A RATIO FOR REVERSE STOCK SPLIT OF 1-FOR-20.  Full Article

Bio-Path Holdings Inc Announces Proposed Public Offering Of Common Stock
Monday, 14 Jan 2019 

Jan 14 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Bio-Path Holdings Reports Q1 Loss Per Share $0.17
Wednesday, 16 May 2018 

May 16 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.17.  Full Article

Bio Path Holdings Provides Clinical Update And 2018 Business Outlook
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS PROVIDES CLINICAL UPDATE AND 2018 BUSINESS OUTLOOK.BIO PATH HOLDINGS INC - ‍ANNOUNCES INITIATION OF ITS PHASE 2A CLINICAL STUDY OF PREXIGEBERSEN FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA​.BIO PATH HOLDINGS INC - INTENDS TO INITIATE A PHASE 1 CLINICAL TRIAL OF BP1002 IN 2018.  Full Article

Bio-Path Holdings Q3 loss per share $0.02
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Bio Path Holdings Inc ::Bio-Path Holdings reports third quarter 2017 financial results.Q3 loss per share $0.02.  Full Article

Bio-Path Holdings announces $4 mln registered direct offering
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Bio Path Holdings Inc :Bio-Path Holdings, Inc. Announces $4 million registered direct offering.Bio Path Holdings Inc - ‍offering of 13.3 million shares of common stock and warrants to purchase up to 6.7 million shares of common stock​.Bio Path Holdings Inc- ‍offering price per share of common stock and one-half warrant is $0.30​.  Full Article